New trials in cardiology

Please contact us at landmarktrials gmail. Or use the form below:. Skip to content Welcome to Landmark Trials beta Where we collect the most impactful research within the fields of Internal Medicine. Finding the evidence Evidence-based medicine is the best way to practice healthcare in our modern age.

Infectious Disease. Update 2 Oct 24, Update 2 is live now! Or use the form below: Name. Message required. Below are current clinical trials. Request an Appointment at Mayo Clinic. Share on: Facebook Twitter. Show references Constans DA expert opinion. Mayo Clinic. Melcher CL expert opinion. July 9, Eleid MF, et al.

Robotic percutaneous coronary intervention: Making gains with experience. Circulation: Cardiovascular Interventions. News Best Hospitals Accessed Oct. Preventative cardiology data included new data with proprotein convertase subtilisin-kexin type 9 PCSK9 inhibitors evolocumab and alirocumab , omega-3 supplements, evinacumab and colchicine in the setting of chronic coronary artery disease. Antiplatelet data included trials evaluating both the optimal length of course following PCI and combination of antiplatelet agents and regimes including combination antithrombotic therapies for patients with atrial fibrillation AF.

Heart failure data included the use of sodium-glucose cotransporter 2 SGLT2 inhibitors sotagliflozin, empagliflozin and dapagliflozin and mavacamten in hypertrophic cardiomyopathy. Electrophysiology trials included early rhythm control in AF and screening for AF.